Kiwa Bio-Tech Products Group Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KWBT research report →
Price Chart
About the company
Kiwa Bio-Tech Products Group Corporation, along with its various subsidiaries, focuses on the research, production, promotion, and distribution of biotechnological solutions for the agricultural industry, primarily serving the People's Republic of China. The company's core offerings include a diverse range of specialized fertilizers such as biological organic, compound microbial, bio-water soluble, and microbial inoculum types, which are formulated using bacillus species and/or photosynthetic bacteria. Established in 2002, Kiwa Bio-Tech is headquartered in Yangling, China.
- CEO
- Ziqi Wang
- IPO
- 2002
- Employees
- 16
- HQ
- Yangling, CN
Get TickerSpark's AI analysis on KWBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $56.48K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -2.99
- Div Yield
- 0.00%
- Gross Margin
- 23.28%
- Op Margin
- -2.96%
- Net Margin
- -16.55%
- ROE
- -59.21%
- ROIC
- -9.43%
Latest fiscal year · YoY change
- Revenue
- $40.09M+30.8%
- Gross Profit
- $9.33M+13.0%
- Op Income
- $-1,186,000
- Net Income
- $-6,635,000-2029.8%
- EPS
- $-0.29-1494.2%
- OCF Growth
- +111.1%
- FCF Growth
- +110.8%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.91
- RSI (14)
- 38
- Avg Volume
- 47.48K
No earnings-call transcripts are available for KWBT yet.
- Free Float
- 99.6%
- Shares Outstanding
- 282.38M
- Float Shares
- 281.37M
Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 15, 16 | LI WEI | other | 1,000,000 |
| Dec 12, 06 | LI WEI | other | 914 |
| Dec 9, 15 | WANG YVONNE | other | 250,000 |
| Apr 1, 16 | WANG YVONNE | other | 240,000 |
| Dec 12, 06 | WANG YVONNE | other | 626 |
| Apr 1, 16 | LI WEI | other | 2,965,324 |
| Dec 12, 06 | LI WEI | other | 914 |
| Feb 18, 09 | Ma Steven Ning | other | 0 |
| Jan 4, 09 | Ma Xin | other | 108,200 |
| Apr 11, 07 | LI WEI | other | 610,278 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our KWBT coverage
Recent articles, reports, and earnings notes.
No research on KWBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KWBT report →Comparing LyondellBasell Industries (NYSE:LYB) & Kiwa Bio-Tech Products Group (OTCMKTS:KWBT)
defenseworld.net · Mar 25
Analyzing Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Kronos Worldwide (NYSE:KRO)
defenseworld.net · Feb 20
Air Products and Chemicals (NYSE:APD) vs. Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) Critical Analysis
defenseworld.net · Feb 9
Reviewing Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Chemours (NYSE:CC)
defenseworld.net · Dec 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.